14 March 2020

Christopher Rhodes: Do plasma metabolomic profiles differentiate responders from non-responders to oral treprostinil? Results from the FREEDOM phase 3 clinical development programme

Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI